Onto Innovation (ONTO) Financials

$120.32 -0.45 (-0.37%)

Closing price 04/15/2025 03:59 PM Eastern

Extended Trading

$117.31 -3.01 (-2.50%)

As of 04/15/2025 07:44 PM Eastern

Annual Income Statements for Onto Innovation

This table shows Onto Innovation's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	2.91	44	33	45	1.91	31	142	223	121	202
Consolidated Net Income / (Loss)	2.91	44	33	45	1.91	31	142	223	121	202
Net Income / (Loss) Continuing Operations	2.91	44	33	45	1.91	31	142	223	121	202
Total Pre-Tax Income	5.57	29	60	53	-0.60	-27	156	242	133	220
Total Operating Income	4.97	29	59	51	-5.04	-27	156	237	116	187
Total Gross Profit	90	114	135	148	135	278	429	539	420	515
Total Revenue	187	221	255	274	306	556	789	1,005	816	987
Operating Revenue	187	221	255	274	306	556	789	1,005	816	987
Total Cost of Revenue	98	107	121	126	171	278	360	466	396	472
Operating Cost of Revenue	98	107	121	126	171	278	360	466	396	472
Total Operating Expenses	85	85	75	97	140	252	273	303	304	328
Selling, General & Admin Expense	22	23	28	34	53	65	68	70	83	86
Marketing Expense	28	30	21	22	28	48	57	66	62	76
Research & Development Expense	33	31	38	40	48	85	96	112	104	117
Amortization Expense	0.11	0.02	1.94	1.53	10	54	51	55	55	49
Total Other Income / (Expense), net	0.60	0.04	0.51	2.26	4.45	0.19	-0.73	4.87	17	33
Interest & Investment Income	0.07	0.04	0.97	2.21	3.67	2.90	1.16	5.01	20	33
Other Income / (Expense), net	0.81	0.29	-0.46	0.06	0.78	-2.71	-1.89	-0.14	-3.85	-0.15
Income Tax Expense	2.66	-15	27	8.25	-2.51	-4.16	13	18	11	19
Basic Earnings per Share	$0.12	$1.79	$1.30	$1.77	$0.06	$0.63	$2.89	$4.52	$2.47	$4.09
Weighted Average Basic Shares Outstanding	24.06M	24.66M	25.33M	25.47M	29.73M	49.14M	49.24M	49.42M	48.97M	49.34M
Diluted Earnings per Share	$0.12	$1.75	$1.27	$1.74	$0.06	$0.63	$2.86	$4.49	$2.46	$4.06
Weighted Average Diluted Shares Outstanding	24.38M	25.15M	25.87M	25.90M	30.01M	49.48M	49.73M	49.76M	49.32M	49.66M
Weighted Average Basic & Diluted Shares Outstanding	24.20M	24.60M	25.40M	24.10M	50.28M	48.88M	49.36M	48.75M	49.13M	49.27M

This table shows Onto Innovation's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	52	66	29	26	36	30	47	53	53	49
Consolidated Net Income / (Loss)	52	66	29	26	36	30	47	53	53	49
Net Income / (Loss) Continuing Operations	52	66	29	26	36	30	47	53	53	49
Total Pre-Tax Income	60	66	32	28	39	34	51	57	61	51
Total Operating Income	59	61	29	25	34	28	43	49	53	42
Total Gross Profit	139	137	105	100	107	108	118	128	136	132
Total Revenue	254	253	199	191	207	219	229	242	252	264
Operating Revenue	254	253	199	191	207	219	229	242	252	264
Total Cost of Revenue	115	116	94	90	100	111	111	114	116	132
Operating Cost of Revenue	115	116	94	90	100	111	111	114	116	132
Total Operating Expenses	80	76	76	76	73	80	76	79	83	90
Selling, General & Admin Expense	17	18	19	19	18	27	18	20	22	26
Marketing Expense	17	16	16	16	15	15	18	19	19	19
Research & Development Expense	32	28	27	27	26	24	27	27	28	35
Amortization Expense	14	14	14	14	14	13	13	13	13	10
Total Other Income / (Expense), net	0.55	4.34	3.17	3.05	4.69	5.60	8.15	8.44	7.94	8.81
Interest & Investment Income	1.52	2.46	3.45	4.76	5.69	6.46	7.36	8.50	8.67	8.97
Other Income / (Expense), net	-0.96	1.88	-0.28	-1.71	-1.00	-0.86	0.79	-0.06	-0.72	-0.15
Income Tax Expense	7.65	-0.66	3.13	1.96	2.81	3.52	4.04	4.32	7.96	2.45
Basic Earnings per Share	$1.05	$1.35	$0.60	$0.53	$0.73	$0.61	$0.95	$1.07	$1.07	$1.00
Weighted Average Basic Shares Outstanding	49.68M	49.42M	48.79M	48.98M	49.04M	48.97M	49.23M	49.34M	49.43M	49.34M
Diluted Earnings per Share	$1.05	$1.34	$0.59	$0.53	$0.73	$0.61	$0.94	$1.07	$1.07	$0.98
Weighted Average Diluted Shares Outstanding	49.95M	49.76M	49.11M	49.27M	49.40M	49.32M	49.64M	49.67M	49.69M	49.66M
Weighted Average Basic & Diluted Shares Outstanding	49.52M	48.75M	48.95M	49.07M	49.08M	49.13M	49.28M	49.38M	49.39M	49.27M

This table details how cash moves in and out of Onto Innovation's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	3.48	8.91	30	45	18	-52	33	24	82	-21
Net Cash From Operating Activities	1.57	46	64	35	18	106	175	137	172	246
Net Cash From Continuing Operating Activities	1.57	46	64	35	18	50	175	148	195	246
Net Income / (Loss) Continuing Operations	2.91	44	33	45	1.91	31	142	223	121	202
Consolidated Net Income / (Loss)	2.91	44	33	45	1.91	31	142	223	121	202
Depreciation Expense	9.08	8.30	3.99	4.85	5.97	14	14	9.38	12	13
Amortization Expense	-	-	1.94	1.53	26	64	52	55	55	49
Non-Cash Adjustments To Reconcile Net Income	9.02	11	9.87	11	24	37	30	40	39	53
Changes in Operating Assets and Liabilities, net	-19	-17	15	-27	-39	-97	-63	-180	-32	-71
Net Cash From Investing Activities	1.95	-42	-33	34	4.10	49	-142	-56	-103	-227
Net Cash From Continuing Investing Activities	1.95	-42	-33	34	4.10	-49	-142	-56	-103	-227
Purchase of Property, Plant & Equipment	-1.85	-4.00	-10	-7.54	-6.80	-3.83	-12	-18	-23	-32
Acquisitions	-	0.00	-1.00	-	0.00	0.00	-24	-4.64	0.00	-27
Purchase of Investments	-41	-83	-165	-140	-127	-313	-361	-371	-480	-709
Sale of Property, Plant & Equipment	-	0.00	-	-	-	-	0.00	0.00	2.80	0.00
Sale and/or Maturity of Investments	45	45	143	186	94	265	255	339	397	541
Net Cash From Financing Activities	0.22	5.27	-2.55	-24	-4.20	-54	2.67	-68	-9.48	-36
Net Cash From Continuing Financing Activities	0.22	5.27	-2.55	-24	-4.20	-54	2.67	-68	-9.48	-36
Repurchase of Common Equity	-1.72	0.00	-1.03	-21	-0.74	-52	0.00	-65	-3.20	-25
Issuance of Common Equity	3.97	8.45	0.62	0.62	0.84	2.92	10	8.07	5.29	9.18
Other Financing Activities, net	-1.18	-2.86	-2.15	-3.46	-4.30	-4.62	-7.40	-11	-12	-20
Effect of Exchange Rate Changes	-0.26	0.08	0.81	-0.34	0.23	-	-	-	-	-4.02
Cash Income Taxes Paid	-0.83	3.77	15	4.30	-3.85	0.00	24	59	34	36

This table details how cash moves in and out of Onto Innovation's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	39	-25	55	-6.23	-18	51	-43	-18	16	24
Net Cash From Operating Activities	32	49	50	32	29	62	57	65	67	56
Net Cash From Continuing Operating Activities	32	61	53	29	29	84	57	65	67	56
Net Income / (Loss) Continuing Operations	52	66	29	26	36	30	47	53	53	49
Consolidated Net Income / (Loss)	52	66	29	26	36	30	47	53	53	49
Depreciation Expense	2.31	2.40	2.92	2.90	3.20	3.37	3.39	3.53	3.90	2.05
Amortization Expense	14	14	14	14	14	13	13	13	13	10
Non-Cash Adjustments To Reconcile Net Income	14	6.70	12	9.30	7.64	9.49	7.99	9.85	9.81	25
Changes in Operating Assets and Liabilities, net	-50	-29	-4.64	-23	-32	28	-14	-14	-13	-30
Net Cash From Investing Activities	3.98	-26	-13	-9.66	-43	-37	-92	-74	-57	-4.10
Net Cash From Continuing Investing Activities	13	-36	13	-36	-43	-37	-92	-74	-57	-4.10
Purchase of Property, Plant & Equipment	-2.88	-8.62	-7.86	-4.61	-7.65	-2.46	-6.98	-12	-8.05	-4.63
Purchase of Investments	-115	-82	-89	-121	-151	-120	-208	-187	-143	-171
Sale and/or Maturity of Investments	126	64	110	89	115	83	123	125	95	198
Net Cash From Financing Activities	-12	-50	-9.47	1.31	-0.92	-0.39	-5.07	-8.87	3.95	-26
Net Cash From Continuing Financing Activities	-12	-50	-9.47	1.31	-0.92	-0.39	-5.07	-8.87	3.95	-26
Repurchase of Common Equity	-12	-54	-3.20	-	-	-	0.00	-	-	-25
Other Financing Activities, net	-0.23	-0.31	-6.27	-3.98	-0.92	-0.39	-9.09	-8.87	-1.22	-0.60
Effect of Exchange Rate Changes	-	-	-	-	-2.03	-	-2.86	-	-	-2.02
Cash Income Taxes Paid	14	12	0.81	18	10	5.17	0.92	21	8.71	5.27

This table presents Onto Innovation's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	236	288	310	418	1,449	1,468	1,650	1,795	1,910	2,117
Total Current Assets	178	216	240	351	642	732	948	1,135	1,283	1,478
Cash & Equivalents	38	47	35	112	131	137	170	176	234	213
Short-Term Investments	45	83	82	63	190	237	342	372	464	639
Accounts Receivable	38	39	62	64	124	149	177	241	227	308
Inventories, net	51	41	54	97	176	191	243	324	328	287
Prepaid Expenses	6.59	5.67	6.23	15	22	17	16	21	31	30
Plant, Property, & Equipment, net	44	44	45	19	98	88	82	92	104	124
Total Noncurrent Assets	13	27	25	48	708	649	620	568	523	516
Goodwill	9.42	8.94	10	22	307	307	316	316	316	330
Intangible Assets	1.87	0.41	2.21	7.45	372	318	277	222	167	127
Noncurrent Deferred & Refundable Income Taxes	1.12	17	12	13	1.46	2.24	4.82	4.78	19	43
Other Noncurrent Operating Assets	0.53	0.47	0.41	5.51	28	21	22	25	21	15
Total Liabilities & Shareholders' Equity	236	288	310	418	1,449	1,468	1,650	1,795	1,910	2,117
Total Liabilities	48	44	47	56	185	203	224	198	173	191
Total Current Liabilities	45	42	44	45	86	120	155	161	148	170
Accounts Payable	12	11	14	17	28	40	53	55	50	56
Accrued Expenses	-	-	-	14	26	37	43	49	42	50
Current Deferred Revenue	13	9.17	7.41	6.77	13	14	30	30	25	34
Other Current Liabilities	8.88	8.05	7.25	7.54	19	28	28	27	31	30
Total Noncurrent Liabilities	3.00	2.03	3.22	11	99	83	69	38	25	21
Noncurrent Deferred & Payable Income Tax Liabilities	0.52	0.02	0.18	0.00	67	56	40	7.37	0.00	0.00
Other Noncurrent Operating Liabilities	0.88	0.35	0.52	11	32	28	29	31	25	21
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	187	244	262	362	1,264	1,265	1,426	1,596	1,737	1,926
Total Preferred & Common Equity	187	244	262	362	1,264	1,265	1,426	1,596	1,737	1,926
Preferred Stock	0.00	0.00	0.00	-	-	0.00	-	0.00	0.00	0.00
Total Common Equity	187	244	262	362	1,264	1,265	1,426	1,596	1,737	1,926
Common Stock	259	272	255	370	1,269	1,234	1,256	1,244	1,262	1,275
Retained Earnings	-66	-22	9.11	-6.77	-4.86	26	169	363	482	665
Accumulated Other Comprehensive Income / (Loss)	-5.20	-6.05	-2.12	-1.26	-0.60	4.57	1.32	-10	-7.90	-14

This table presents Onto Innovation's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	1,788	1,803	1,821	1,862	1,953	2,005	2,073
Total Current Assets	1,123	1,155	1,183	1,221	1,333	1,385	1,458
Cash & Equivalents	200	230	224	207	191	173	189
Short-Term Investments	352	353	385	423	550	613	667
Accounts Receivable	236	210	188	210	232	238	254
Inventories, net	308	338	352	346	330	320	308
Prepaid Expenses	27	24	34	36	31	42	41
Plant, Property, & Equipment, net	84	98	100	104	107	115	120
Total Noncurrent Assets	581	550	538	537	514	505	495
Goodwill	316	316	316	316	316	316	316
Intangible Assets	236	208	195	181	154	141	128
Noncurrent Deferred & Refundable Income Taxes	4.29	4.79	8.32	18	24	29	35
Other Noncurrent Operating Assets	25	21	19	22	19	18	17
Total Liabilities & Shareholders' Equity	1,788	1,803	1,821	1,862	1,953	2,005	2,073
Total Liabilities	218	178	164	166	172	174	170
Total Current Liabilities	170	148	137	136	147	148	145
Accounts Payable	64	54	50	44	56	51	48
Accrued Expenses	45	38	36	39	35	40	44
Current Deferred Revenue	29	28	24	23	26	28	27
Other Current Liabilities	31	29	27	29	30	28	26
Total Noncurrent Liabilities	49	30	27	30	25	25	25
Noncurrent Deferred & Payable Income Tax Liabilities	16	1.74	0.00	0.00	0.00	0.00	0.00
Other Noncurrent Operating Liabilities	33	28	27	30	25	25	25
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,569	1,625	1,657	1,696	1,782	1,832	1,904
Total Preferred & Common Equity	1,569	1,625	1,657	1,696	1,782	1,832	1,904
Total Common Equity	1,569	1,625	1,657	1,696	1,782	1,832	1,904
Common Stock	1,260	1,242	1,251	1,257	1,263	1,263	1,275
Retained Earnings	326	390	416	452	529	582	635
Accumulated Other Comprehensive Income / (Loss)	-16	-7.53	-11	-13	-11	-13	-6.33

This table displays calculated financial ratios and metrics derived from Onto Innovation's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	12.57%	18.02%	15.36%	7.33%	11.73%	81.92%	41.76%	27.42%	-18.83%	21.01%
EBITDA Growth	1,082.87%	153.55%	71.87%	-11.18%	-52.16%	77.60%	351.62%	36.48%	-40.43%	38.92%
EBIT Growth	151.30%	407.86%	100.21%	-13.07%	-108.34%	-589.30%	625.84%	53.10%	-52.56%	66.59%
NOPAT Growth	131.81%	1,594.87%	-25.81%	32.36%	-108.17%	-428.99%	865.84%	53.02%	-51.53%	61.36%
Net Income Growth	109.34%	1,415.83%	-25.27%	37.03%	-95.76%	1,524.35%	358.82%	56.89%	-45.75%	66.45%
EPS Growth	109.23%	1,358.33%	-27.43%	37.01%	-96.55%	950.00%	353.97%	56.99%	-45.21%	65.04%
Operating Cash Flow Growth	347.40%	2,808.02%	40.46%	-45.31%	-48.29%	484.06%	65.38%	-22.01%	25.80%	42.86%
Free Cash Flow Firm Growth	-156.35%	666.48%	-96.85%	58.67%	-44,268.62%	104.48%	250.00%	-28.85%	36.62%	17.54%
Invested Capital Growth	9.07%	9.18%	27.71%	28.52%	405.20%	-5.59%	2.66%	14.64%	-0.95%	3.35%
Revenue Q/Q Growth	1.62%	8.05%	6.48%	-15.02%	44.55%	6.62%	9.82%	2.83%	-4.05%	4.78%
EBITDA Q/Q Growth	33.37%	34.99%	60.93%	-39.27%	57.65%	-34.65%	67.74%	4.26%	-16.41%	4.34%
EBIT Q/Q Growth	80.25%	52.85%	77.38%	-43.79%	-130.08%	-117.36%	136.12%	5.96%	-24.15%	8.68%
NOPAT Q/Q Growth	4,256.71%	180.41%	-28.13%	-26.55%	-125.82%	-134.15%	126.37%	7.69%	-25.55%	9.74%
Net Income Q/Q Growth	3,577.22%	182.86%	-28.55%	-23.73%	-90.02%	567.17%	23.22%	9.55%	-22.86%	10.10%
EPS Q/Q Growth	0.00%	186.89%	-29.83%	-26.89%	-90.91%	226.00%	22.22%	10.05%	-22.88%	10.03%
Operating Cash Flow Q/Q Growth	-86.05%	37.09%	137.95%	-73.45%	177.50%	60.33%	9.96%	0.36%	7.56%	-2.22%
Free Cash Flow Firm Q/Q Growth	-347.74%	65.86%	-88.43%	-97.60%	-1,087.42%	104.83%	146.24%	-13.84%	25.17%	-21.80%
Invested Capital Q/Q Growth	1.04%	16.00%	8.37%	54.22%	374.61%	-0.70%	0.30%	3.15%	-2.60%	2.43%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	47.86%	51.61%	52.76%	54.16%	44.14%	50.04%	54.39%	53.64%	51.51%	52.19%
EBITDA Margin	7.93%	17.04%	25.39%	21.01%	9.00%	8.78%	27.98%	29.97%	21.99%	25.25%
Operating Margin	2.65%	13.16%	23.24%	18.66%	-1.65%	-4.79%	19.83%	23.55%	14.23%	18.95%
EBIT Margin	3.09%	13.29%	23.06%	18.68%	-1.39%	-5.28%	19.59%	23.54%	13.76%	18.94%
Profit (Net Income) Margin	1.55%	19.91%	12.90%	16.47%	0.62%	5.58%	18.04%	22.22%	14.85%	20.43%
Tax Burden Percent	52.17%	151.14%	55.03%	84.53%	-319.93%	-115.47%	91.44%	92.45%	91.38%	91.48%
Interest Burden Percent	96.23%	99.15%	101.65%	104.31%	14.00%	91.43%	100.75%	102.12%	118.14%	117.91%
Effective Tax Rate	47.83%	-51.14%	44.97%	15.47%	0.00%	0.00%	8.56%	7.55%	8.62%	8.52%
Return on Invested Capital (ROIC)	2.60%	40.33%	25.18%	26.00%	-0.62%	-2.04%	15.84%	22.29%	10.16%	16.21%
ROIC Less NNEP Spread (ROIC-NNEP)	2.23%	40.28%	24.95%	24.69%	-2.82%	-16.36%	15.99%	21.44%	7.74%	12.27%
Return on Net Nonoperating Assets (RNNOA)	-1.01%	-19.90%	-12.17%	-11.55%	0.86%	4.49%	-5.26%	-7.51%	-2.89%	-5.19%
Return on Equity (ROE)	1.58%	20.43%	13.00%	14.45%	0.23%	2.45%	10.58%	14.78%	7.27%	11.01%
Cash Return on Invested Capital (CROIC)	-6.08%	31.56%	0.84%	1.04%	-134.53%	3.72%	13.22%	8.65%	11.11%	12.91%
Operating Return on Assets (OROA)	2.52%	11.23%	19.69%	14.05%	-0.46%	-2.01%	9.91%	13.74%	6.06%	9.29%
Return on Assets (ROA)	1.27%	16.83%	11.02%	12.39%	0.20%	2.13%	9.13%	12.97%	6.54%	10.02%
Return on Common Equity (ROCE)	1.58%	20.43%	13.00%	14.45%	0.23%	2.45%	10.58%	14.78%	7.27%	11.01%
Return on Equity Simple (ROE_SIMPLE)	1.55%	18.06%	12.54%	12.46%	0.15%	2.45%	9.98%	13.99%	6.98%	10.47%
Net Operating Profit after Tax (NOPAT)	2.59	44	33	43	-3.53	-19	143	219	106	171
NOPAT Margin	1.38%	19.89%	12.79%	15.77%	-1.15%	-3.36%	18.13%	21.77%	13.00%	17.34%
Net Nonoperating Expense Percent (NNEP)	0.37%	0.06%	0.23%	1.31%	2.20%	14.32%	-0.15%	0.85%	2.42%	3.94%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	13.71%	6.11%	8.89%
Cost of Revenue to Revenue	52.14%	48.39%	47.24%	45.84%	55.86%	49.96%	45.61%	46.36%	48.49%	47.81%
SG&A Expenses to Revenue	11.98%	10.57%	10.93%	12.31%	17.33%	11.74%	8.61%	6.92%	10.19%	8.69%
R&D to Revenue	17.45%	14.22%	14.78%	14.59%	15.81%	15.20%	12.18%	11.14%	12.80%	11.83%
Operating Expenses to Revenue	45.20%	38.45%	29.52%	35.50%	45.79%	45.24%	34.56%	30.09%	37.28%	33.24%
Earnings before Interest and Taxes (EBIT)	5.79	29	59	51	-4.26	-29	155	237	112	187
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	15	38	65	58	28	49	221	301	179	249
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.04	2.56	2.43	1.83	1.45	1.85	3.50	2.11	4.32	4.38
Price to Tangible Book Value (P/TBV)	2.17	2.66	2.55	1.99	3.13	3.67	5.99	3.19	5.99	5.74
Price to Revenue (P/Rev)	2.04	2.82	2.50	2.42	5.98	4.21	6.32	3.35	9.20	8.54
Price to Earnings (P/E)	131.47	14.18	19.38	14.68	957.73	75.58	35.04	15.10	61.94	41.80
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.76%	7.05%	5.16%	6.81%	0.10%	1.32%	2.85%	6.62%	1.61%	2.39%
Enterprise Value to Invested Capital (EV/IC)	2.87	4.34	3.58	2.61	1.60	2.21	4.89	2.69	6.55	7.06
Enterprise Value to Revenue (EV/Rev)	1.60	2.24	2.04	1.78	4.93	3.54	5.68	2.81	8.34	7.67
Enterprise Value to EBITDA (EV/EBITDA)	20.11	13.12	8.04	8.46	54.84	40.33	20.28	9.37	37.93	30.40
Enterprise Value to EBIT (EV/EBIT)	51.65	16.83	8.85	9.52	0.00	0.00	28.97	11.94	60.65	40.53
Enterprise Value to NOPAT (EV/NOPAT)	115.18	11.24	15.96	11.27	0.00	0.00	31.31	12.90	64.17	44.27
Enterprise Value to Operating Cash Flow (EV/OCF)	190.23	10.82	8.12	13.87	83.16	18.60	25.54	20.66	39.58	30.84
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	14.37	479.93	282.69	0.00	57.82	37.52	33.26	58.68	55.57
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.46	-0.49	-0.49	-0.47	-0.30	-0.27	-0.33	-0.35	-0.37	-0.42
Leverage Ratio	1.25	1.21	1.18	1.17	1.15	1.15	1.16	1.14	1.11	1.10
Compound Leverage Factor	1.20	1.20	1.20	1.22	0.16	1.05	1.17	1.16	1.31	1.30
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	5.91	10.23	10.34	8.99	6.60	7.75	14.88	12.12	27.69	28.39
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.94	5.15	5.45	7.80	7.48	6.09	6.14	7.07	8.69	8.69
Quick Ratio	2.67	4.03	4.07	5.32	5.18	4.35	4.46	4.92	6.26	6.82
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-6.07	34	1.09	1.72	-761	34	119	85	116	136
Operating Cash Flow to CapEx	85.10%	1,142.41%	628.51%	465.31%	266.77%	2,767.93%	1,455.94%	742.75%	869.74%	770.07%
Free Cash Flow to Firm to Interest Expense	-21.02	120.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	5.44	160.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-0.95	146.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.82	0.85	0.85	0.75	0.33	0.38	0.51	0.58	0.44	0.49
Accounts Receivable Turnover	5.86	5.72	5.01	4.32	3.26	4.08	4.83	4.80	3.49	3.69
Inventory Turnover	2.23	2.33	2.52	1.66	1.25	1.51	1.66	1.64	1.21	1.54
Fixed Asset Turnover	3.98	4.98	5.73	8.60	5.22	5.97	9.28	11.55	8.34	8.68
Accounts Payable Turnover	8.93	9.30	9.56	8.14	7.64	8.19	7.69	8.64	7.58	8.90
Days Sales Outstanding (DSO)	62.29	63.79	72.91	84.42	112.07	89.50	75.52	76.00	104.68	98.84
Days Inventory Outstanding (DIO)	163.67	156.74	144.92	219.88	291.54	241.12	220.29	222.23	300.80	237.69
Days Payable Outstanding (DPO)	40.86	39.26	38.16	44.84	47.76	44.58	47.44	42.25	48.16	41.03
Cash Conversion Cycle (CCC)	185.11	181.27	179.67	259.47	355.85	286.04	248.38	255.98	357.32	295.49
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	104	114	145	187	944	891	915	1,049	1,039	1,074
Invested Capital Turnover	1.88	2.03	1.97	1.65	0.54	0.61	0.87	1.02	0.78	0.93
Increase / (Decrease) in Invested Capital	8.67	9.57	32	41	757	-53	24	134	-9.92	35
Enterprise Value (EV)	299	494	521	487	1,509	1,971	4,477	2,824	6,807	7,577
Market Capitalization	382	624	638	662	1,829	2,345	4,988	3,372	7,504	8,429
Book Value per Share	$7.74	$9.78	$10.25	$14.94	$25.25	$25.90	$28.94	$32.24	$35.38	$38.99
Tangible Book Value per Share	$7.28	$9.41	$9.77	$13.71	$11.68	$13.10	$16.90	$21.37	$25.54	$29.73
Total Capital	187	244	262	362	1,264	1,265	1,426	1,596	1,737	1,926
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-83	-130	-117	-175	-320	-374	-511	-548	-698	-852
Capital Expenditures (CapEx)	1.85	4.00	10	7.54	6.80	3.83	12	18	20	32
Debt-free, Cash-free Net Working Capital (DFCFNWC)	50	44	79	131	236	238	282	427	438	455
Debt-free Net Working Capital (DFNWC)	133	174	196	306	556	612	794	974	1,136	1,307
Net Working Capital (NWC)	133	174	196	306	556	612	794	974	1,136	1,307
Net Nonoperating Expense (NNE)	-0.31	-0.06	-0.28	-1.91	-5.44	-50	0.66	-4.50	-15	-31
Net Nonoperating Obligations (NNO)	-83	-130	-117	-175	-320	-374	-511	-548	-698	-852
Total Depreciation and Amortization (D&A)	9.08	8.30	5.93	6.38	32	78	66	65	67	62
Debt-free, Cash-free Net Working Capital to Revenue	26.59%	20.08%	30.96%	47.79%	77.05%	42.74%	35.77%	42.43%	53.65%	46.09%
Debt-free Net Working Capital to Revenue	70.93%	78.85%	76.84%	111.74%	181.74%	109.90%	100.59%	96.93%	139.18%	132.42%
Net Working Capital to Revenue	70.93%	78.85%	76.84%	111.74%	181.74%	109.90%	100.59%	96.93%	139.18%	132.42%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.12	$1.79	$1.19	$2.39	$0.06	$0.63	$2.89	$0.00	$2.47	$4.09
Adjusted Weighted Average Basic Shares Outstanding	24.06M	24.66M	25.33M	24.12M	29.73M	49.14M	49.24M	0.00	48.97M	49.34M
Adjusted Diluted Earnings per Share	$0.12	$1.75	$1.17	$2.34	$0.06	$0.63	$2.86	$0.00	$2.46	$4.06
Adjusted Weighted Average Diluted Shares Outstanding	24.38M	25.15M	25.92M	24.60M	30.01M	49.48M	49.73M	0.00	49.32M	49.66M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	24.30M	25.16M	23.76M	24.46M	50.28M	48.88M	49.36M	0.00	49.13M	49.27M
Normalized Net Operating Profit after Tax (NOPAT)	3.31	20	25	43	-3.53	-19	143	219	106	171
Normalized NOPAT Margin	1.77%	9.21%	9.99%	15.77%	-1.15%	-3.36%	18.13%	21.77%	13.00%	17.34%
Pre Tax Income Margin	2.97%	13.18%	23.44%	19.48%	-0.20%	-4.83%	19.73%	24.03%	16.25%	22.33%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	20.02	103.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	8.98	154.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	13.63	89.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	2.59	140.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	29.29%	0.72%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	88.54%	0.72%	3.11%	46.72%	38.95%	167.61%	0.00%	29.22%	2.64%	12.43%

This table displays calculated financial ratios and metrics derived from Onto Innovation's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	26.75%	12.24%	-17.48%	-25.61%	-18.51%	-13.59%	14.90%	27.10%	21.73%	20.60%
EBITDA Growth	25.41%	18.36%	-39.12%	-45.23%	-32.83%	-44.41%	31.95%	64.28%	38.63%	23.52%
EBIT Growth	36.21%	26.72%	-50.88%	-59.19%	-43.43%	-56.62%	51.39%	111.17%	58.61%	54.57%
NOPAT Growth	41.75%	32.82%	-50.71%	-55.44%	-39.04%	-59.09%	50.12%	95.77%	46.33%	59.83%
Net Income Growth	43.26%	41.67%	-45.49%	-49.79%	-31.27%	-54.23%	61.18%	104.47%	47.83%	61.06%
EPS Growth	43.84%	44.09%	-44.86%	-48.54%	-30.48%	-54.48%	59.32%	101.89%	46.58%	60.66%
Operating Cash Flow Growth	-36.17%	1.01%	10.14%	219.05%	-10.02%	24.43%	14.11%	106.07%	134.87%	-9.07%
Free Cash Flow Firm Growth	-343.06%	-415.37%	-481.00%	-229.75%	65.46%	148.84%	147.15%	213.41%	452.82%	-84.10%
Invested Capital Growth	11.48%	14.64%	11.90%	6.53%	4.90%	-0.95%	-0.05%	-0.14%	-1.72%	3.35%
Revenue Q/Q Growth	-0.80%	-0.39%	-21.36%	-4.27%	8.67%	5.63%	4.56%	5.89%	4.08%	4.65%
EBITDA Q/Q Growth	2.43%	6.49%	-42.64%	-12.47%	25.64%	-11.87%	36.15%	8.97%	6.02%	-21.48%
EBIT Q/Q Growth	3.10%	8.14%	-54.43%	-19.67%	42.90%	-17.07%	59.05%	12.04%	7.33%	-19.18%
NOPAT Q/Q Growth	-0.04%	19.52%	-57.61%	-12.01%	36.73%	-19.79%	55.55%	14.75%	2.20%	-12.39%
Net Income Q/Q Growth	1.24%	26.81%	-56.10%	-10.91%	38.58%	-15.54%	54.58%	13.01%	0.19%	-7.98%
EPS Q/Q Growth	1.94%	27.62%	-55.97%	-10.17%	37.74%	-16.44%	54.10%	13.83%	0.00%	-8.41%
Operating Cash Flow Q/Q Growth	220.38%	55.55%	1.16%	-36.71%	-9.64%	115.10%	-7.23%	14.30%	2.98%	-16.73%
Free Cash Flow Firm Q/Q Growth	-324.62%	-36.22%	-17.18%	51.35%	55.52%	292.61%	13.12%	17.03%	38.37%	-91.32%
Invested Capital Q/Q Growth	3.43%	3.15%	-0.72%	0.58%	1.85%	-2.60%	0.18%	0.48%	0.24%	2.43%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	54.61%	54.18%	52.71%	52.69%	51.57%	49.33%	51.69%	52.92%	54.07%	50.17%
EBITDA Margin	29.29%	31.32%	22.84%	20.89%	24.15%	20.15%	26.23%	27.00%	27.50%	20.63%
Operating Margin	23.33%	24.17%	14.58%	13.01%	16.41%	12.90%	18.68%	20.15%	21.04%	16.09%
EBIT Margin	22.95%	24.91%	14.44%	12.11%	15.93%	12.51%	19.02%	20.13%	20.76%	16.03%
Profit (Net Income) Margin	20.54%	26.14%	14.59%	13.58%	17.32%	13.85%	20.47%	21.85%	21.03%	18.50%
Tax Burden Percent	87.23%	101.01%	90.27%	92.97%	92.73%	89.60%	92.06%	92.46%	86.95%	95.21%
Interest Burden Percent	102.60%	103.89%	111.99%	120.60%	117.25%	123.59%	116.91%	117.42%	116.56%	121.19%
Effective Tax Rate	12.77%	-1.01%	9.73%	7.03%	7.27%	10.40%	7.94%	7.54%	13.05%	4.79%
Return on Invested Capital (ROIC)	20.63%	25.00%	12.86%	10.69%	12.43%	9.03%	13.97%	15.98%	16.31%	14.32%
ROIC Less NNEP Spread (ROIC-NNEP)	20.53%	24.17%	12.35%	10.20%	11.69%	8.23%	12.83%	14.86%	15.38%	13.24%
Return on Net Nonoperating Assets (RNNOA)	-7.08%	-8.47%	-4.49%	-3.70%	-4.23%	-3.08%	-4.99%	-5.94%	-6.34%	-5.60%
Return on Equity (ROE)	13.55%	16.53%	8.37%	6.99%	8.19%	5.96%	8.98%	10.03%	9.96%	8.72%
Cash Return on Invested Capital (CROIC)	10.22%	8.65%	8.23%	9.74%	8.90%	11.11%	11.50%	13.64%	16.49%	12.91%
Operating Return on Assets (OROA)	13.23%	14.54%	7.89%	6.07%	7.42%	5.51%	8.56%	9.44%	9.94%	7.86%
Return on Assets (ROA)	11.84%	15.26%	7.97%	6.80%	8.07%	6.10%	9.22%	10.25%	10.07%	9.07%
Return on Common Equity (ROCE)	13.55%	16.53%	8.37%	6.99%	8.19%	5.96%	8.98%	10.03%	9.96%	8.72%
Return on Equity Simple (ROE_SIMPLE)	12.99%	0.00%	12.25%	10.47%	9.26%	0.00%	7.80%	9.06%	9.62%	0.00%
Net Operating Profit after Tax (NOPAT)	52	62	26	23	32	25	39	45	46	40
NOPAT Margin	20.35%	24.41%	13.16%	12.10%	15.22%	11.56%	17.19%	18.63%	18.30%	15.32%
Net Nonoperating Expense Percent (NNEP)	0.10%	0.83%	0.51%	0.49%	0.74%	0.81%	1.13%	1.12%	0.93%	1.08%
Return On Investment Capital (ROIC_SIMPLE)	-	3.87%	-	-	-	1.46%	-	-	-	2.10%
Cost of Revenue to Revenue	45.39%	45.82%	47.29%	47.31%	48.43%	50.67%	48.31%	47.08%	45.93%	49.83%
SG&A Expenses to Revenue	6.61%	7.10%	9.66%	9.84%	8.75%	12.34%	7.67%	8.37%	8.91%	9.68%
R&D to Revenue	12.64%	10.99%	13.68%	14.18%	12.61%	10.98%	11.60%	11.16%	11.21%	13.22%
Operating Expenses to Revenue	31.28%	30.01%	38.13%	39.68%	35.16%	36.43%	33.01%	32.77%	33.03%	34.08%
Earnings before Interest and Taxes (EBIT)	58	63	29	23	33	27	44	49	52	42
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	74	79	45	40	50	44	60	65	69	54
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.03	2.11	2.64	3.44	3.69	4.32	4.99	5.91	5.59	4.38
Price to Tangible Book Value (P/TBV)	3.13	3.19	3.89	4.97	5.22	5.99	6.78	7.87	7.29	5.74
Price to Revenue (P/Rev)	3.26	3.35	4.45	6.35	7.36	9.20	10.51	12.06	11.29	8.54
Price to Earnings (P/E)	15.61	15.10	21.52	32.88	39.84	61.94	63.97	65.18	58.07	41.80
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	6.41%	6.62%	4.65%	3.04%	2.51%	1.61%	1.56%	1.53%	1.72%	2.39%
Enterprise Value to Invested Capital (EV/IC)	2.59	2.69	3.55	4.86	5.28	6.55	7.83	9.60	9.33	7.06
Enterprise Value to Revenue (EV/Rev)	2.69	2.81	3.84	5.67	6.62	8.34	9.63	11.18	10.38	7.67
Enterprise Value to EBITDA (EV/EBITDA)	9.10	9.37	13.61	21.29	26.21	37.93	42.00	45.69	40.94	30.40
Enterprise Value to EBIT (EV/EBIT)	11.78	11.94	17.90	29.38	38.03	60.65	64.15	65.71	56.86	40.53
Enterprise Value to NOPAT (EV/NOPAT)	12.94	12.90	19.30	31.23	39.49	64.17	68.34	71.00	62.70	44.27
Enterprise Value to Operating Cash Flow (EV/OCF)	19.30	20.66	26.19	31.22	35.20	39.58	45.50	47.18	38.92	30.84
Enterprise Value to Free Cash Flow (EV/FCFF)	26.68	33.26	45.64	51.51	60.72	58.68	68.06	70.27	56.10	55.57
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.34	-0.35	-0.36	-0.36	-0.36	-0.37	-0.39	-0.40	-0.41	-0.42
Leverage Ratio	1.15	1.14	1.14	1.12	1.12	1.11	1.10	1.10	1.09	1.10
Compound Leverage Factor	1.18	1.18	1.27	1.36	1.31	1.37	1.29	1.29	1.27	1.33
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	10.29	11.80	15.98	22.38	24.16	27.54	32.65	39.04	39.30	28.16
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	6.62	7.07	7.78	8.64	9.00	8.69	9.06	9.33	10.07	8.69
Quick Ratio	4.65	4.92	5.34	5.82	6.18	6.26	6.62	6.90	7.66	6.82
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-53	-72	-84	-41	-18	35	40	47	65	5.60
Operating Cash Flow to CapEx	1,103.33%	574.25%	637.39%	687.67%	374.42%	2,500.45%	819.08%	532.92%	835.47%	1,210.53%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.58	0.58	0.55	0.50	0.47	0.44	0.45	0.47	0.48	0.49
Accounts Receivable Turnover	4.71	4.80	4.63	4.25	3.82	3.49	3.83	4.22	4.07	3.69
Inventory Turnover	1.70	1.64	1.50	1.31	1.23	1.21	1.23	1.30	1.38	1.54
Fixed Asset Turnover	11.50	11.55	10.74	9.81	9.02	8.34	8.27	8.33	8.40	8.68
Accounts Payable Turnover	7.87	8.64	7.23	6.83	7.39	7.58	7.52	8.63	9.76	8.90
Days Sales Outstanding (DSO)	77.53	76.00	78.90	85.94	95.52	104.68	95.29	86.59	89.72	98.84
Days Inventory Outstanding (DIO)	214.18	222.23	243.98	277.67	297.78	300.80	295.85	281.28	264.57	237.69
Days Payable Outstanding (DPO)	46.38	42.25	50.49	53.48	49.37	48.16	48.55	42.28	37.38	41.03
Cash Conversion Cycle (CCC)	245.33	255.98	272.39	310.13	343.93	357.32	342.59	325.58	316.91	295.49
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,017	1,049	1,041	1,047	1,066	1,039	1,041	1,046	1,048	1,074
Invested Capital Turnover	1.01	1.02	0.98	0.88	0.82	0.78	0.81	0.86	0.89	0.93
Increase / (Decrease) in Invested Capital	105	134	111	64	50	-9.92	-0.49	-1.47	-18	35
Enterprise Value (EV)	2,629	2,824	3,701	5,091	5,627	6,807	8,147	10,033	9,780	7,577
Market Capitalization	3,182	3,372	4,285	5,701	6,257	7,504	8,888	10,819	10,636	8,429
Book Value per Share	$31.59	$32.24	$33.32	$33.85	$34.57	$35.38	$36.19	$37.17	$38.55	$38.99
Tangible Book Value per Share	$20.48	$21.37	$22.57	$23.42	$24.45	$25.54	$26.64	$27.90	$29.56	$29.73
Total Capital	1,569	1,596	1,625	1,657	1,696	1,737	1,782	1,832	1,904	1,926
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-553	-548	-584	-610	-630	-698	-741	-786	-855	-852
Capital Expenditures (CapEx)	2.88	8.62	7.86	4.61	7.65	2.46	6.98	12	8.05	4.63
Debt-free, Cash-free Net Working Capital (DFCFNWC)	400	427	423	437	456	438	445	451	458	455
Debt-free Net Working Capital (DFNWC)	953	974	1,007	1,046	1,085	1,136	1,186	1,237	1,313	1,307
Net Working Capital (NWC)	953	974	1,007	1,046	1,085	1,136	1,186	1,237	1,313	1,307
Net Nonoperating Expense (NNE)	-0.48	-4.38	-2.86	-2.83	-4.35	-5.01	-7.51	-7.80	-6.91	-8.39
Net Nonoperating Obligations (NNO)	-553	-548	-584	-610	-630	-698	-741	-786	-855	-852
Total Depreciation and Amortization (D&A)	16	16	17	17	17	17	17	17	17	12
Debt-free, Cash-free Net Working Capital to Revenue	40.96%	42.43%	43.94%	48.64%	53.60%	53.65%	52.61%	50.24%	48.59%	46.09%
Debt-free Net Working Capital to Revenue	97.50%	96.93%	104.54%	116.58%	127.66%	139.18%	140.24%	137.85%	139.37%	132.42%
Net Working Capital to Revenue	97.50%	96.93%	104.54%	116.58%	127.66%	139.18%	140.24%	137.85%	139.37%	132.42%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.05	$1.35	$0.60	$0.53	$0.73	$0.61	$0.95	$1.07	$1.07	$1.00
Adjusted Weighted Average Basic Shares Outstanding	49.68M	49.42M	48.79M	48.98M	49.04M	48.97M	49.23M	49.34M	49.43M	49.34M
Adjusted Diluted Earnings per Share	$1.05	$1.34	$0.59	$0.53	$0.73	$0.61	$0.94	$1.07	$1.07	$0.98
Adjusted Weighted Average Diluted Shares Outstanding	49.95M	49.76M	49.11M	49.27M	49.40M	49.32M	49.64M	49.67M	49.69M	49.66M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	49.52M	48.75M	48.95M	49.07M	49.08M	49.13M	49.28M	49.38M	49.39M	49.27M
Normalized Net Operating Profit after Tax (NOPAT)	52	43	26	23	32	25	39	45	46	40
Normalized NOPAT Margin	20.35%	16.92%	13.16%	12.10%	15.22%	11.56%	17.19%	18.63%	18.30%	15.32%
Pre Tax Income Margin	23.54%	25.88%	16.17%	14.61%	18.68%	15.46%	22.24%	23.63%	24.19%	19.43%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	5.66%	29.22%	34.39%	39.48%	36.24%	2.64%	0.00%	0.00%	0.00%	12.43%

Frequently Asked Questions About Onto Innovation's Financials

When does Onto Innovation's financial year end?

According to the most recent income statement we have on file, Onto Innovation's fiscal year ends in December. Their fiscal year 2024 ended on December 28, 2024.

How has Onto Innovation's net income changed over the last 9 years?

Onto Innovation's net income appears to be on an upward trend, with a most recent value of $201.67 million in 2024, rising from $2.91 million in 2015. The previous period was $121.16 million in 2023.

What is Onto Innovation's operating income?

Onto Innovation's total operating income in 2024 was $187.10 million, based on the following breakdown:

Total Gross Profit: $515.31 million
Total Operating Expenses: $328.21 million

How has Onto Innovation revenue changed over the last 9 years?

Over the last 9 years, Onto Innovation's total revenue changed from $187.37 million in 2015 to $987.32 million in 2024, a change of 426.9%.

How much debt does Onto Innovation have?

Onto Innovation's total liabilities were at $191.21 million at the end of 2024, a 10.4% increase from 2023, and a 296.6% increase since 2015.

How much cash does Onto Innovation have?

In the past 9 years, Onto Innovation's cash and equivalents has ranged from $34.90 million in 2017 to $233.51 million in 2023, and is currently $212.95 million as of their latest financial filing in 2024.

How has Onto Innovation's book value per share changed over the last 9 years?

Over the last 9 years, Onto Innovation's book value per share changed from 7.74 in 2015 to 38.99 in 2024, a change of 403.5%.

Remove Ads

Related Companies

This page (NYSE:ONTO) was last updated on 4/16/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Onto Innovation (ONTO) Financials

Frequently Asked Questions About Onto Innovation's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Onto Innovation (ONTO) Financials

Annual Income Statements for Onto Innovation

Quarterly Income Statements for Onto Innovation

Annual Cash Flow Statements for Onto Innovation

Quarterly Cash Flow Statements for Onto Innovation

Annual Balance Sheets for Onto Innovation

Quarterly Balance Sheets for Onto Innovation

Annual Metrics and Ratios for Onto Innovation

Quarterly Metrics and Ratios for Onto Innovation

Frequently Asked Questions About Onto Innovation's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools